rxstat › Classes › Antithrombotic Agents

Antithrombotic Agents: shortage status in Canada

8 of the 25 antithrombotic agents rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Nadroparin (Fraxiparine) Widespread shortage 7 of 8 reported products affected Clopidogrel (Plavix) Partial shortage 5 of 18 reported products affected · est. return Nov 10, 2026 Dabigatran Etexilate (Pradaxa) Partial shortage 2 of 6 reported products affected Edoxaban (Lixiana) Partial shortage 2 of 8 reported products affected Rivaroxaban (Xarelto) Partial shortage 3 of 18 reported products affected · est. return Nov 30, 2026 Ticagrelor Partial shortage 1 of 4 reported products affected Ticlopidine Partial shortage 1 of 1 reported products affected Warfarin (Coumadin) Partial shortage 1 of 23 reported products affected Heparin Shortage anticipated 0 of 11 reported products affected Tinzaparin (Innohep) Shortage anticipated 0 of 11 reported products affected Abciximab (Reopro) Discontinued 0 of 1 reported products affected Acenocoumarol (Sintrom) Discontinued 0 of 2 reported products affected Acetylsalicylic Acid Dipyridamole (Aggrenox) Discontinued 0 of 2 reported products affected Alteplase (Cathflo) No current shortage Apixaban No current shortage Argatroban No current shortage Bivalirudin (Angiomax) No current shortage Dipyridamole (Persantine) No current shortage Enoxaparin (Lovenox) No current shortage Epoprostenol (Flolan) No current shortage Eptifibatide (Integrilin) Discontinued 0 of 4 reported products affected Heparin Dextrose No current shortage Heparin Dibasic Citric Acid Dextrose No current shortage Rivaroxaban (Xarelto) Discontinued 0 of 1 reported products affected Water Alteplase (Activase Rt-Pa) Discontinued 0 of 1 reported products affected

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.